Over the past 12 months, information about the SARS-CoV-2 virus (or COVID-19 as it is commonly known) continues to emerge. A wealth of information appears on the website of the U.S. Centers for Disease Control and Prevention (2021) about the virus, management, vaccines, quarantine, and new variants. A search of the National Library of Medicine’s (NLM) National Center for Biotechnology Information’s database (PubMed) identified over 90,000 COVID-19 related articles already in print from around the world (NLM, 2021). Approximately 800 clinical trials examining a variety of biologics for COVID-19 intervention are also underway (all phases) worldwide (NLM ClinicalTrials.gov, 2021).
The role of audiology in the management of COVID-19 patients has emerged as survivors begin to experience a continuance of their health issues post-discharge or a late onset of medical problems. This group of patients has been referred to as COVID-19 “long-haulers.” COVID-19 survivors may also experience auditory/vestibular problems. DiSogra (2020) addresses this issue in detail and offers suggestions for ongoing monitoring.
This article will address whether COVID-19 can be found in cerumen and what precautions need to be taken with current patients and ‘long-haulers.’
Recent Posts
Founders’ Day
The 32 audiologists gathered in Houston, Texas, in 1988 to discuss the formation of a national association of audiologists. On January 30, 1988, 32 audiologists met…
House Minibus Advances with Mixed Outcomes for EHDI
Last week, the U.S. House of Representatives passed a fiscal year (FY) 2026 minibus appropriations package that includes the Labor, Health and Human Services, and…
State Policy Advocate Network Kicks Off 2026
The State Policy Advocate Network (SPAN) will hold its first meeting of 2026 on January 28 from 8:00–9:00 pm ET. This opening meeting of the…


